SAN

75.09

+2.65%↑

ARGX

667

-1.83%↓

SHL.DE

34.19

+3.48%↑

FRE

39.62

+3.04%↑

PHIA

22.56

+4.2%↑

SAN

75.09

+2.65%↑

ARGX

667

-1.83%↓

SHL.DE

34.19

+3.48%↑

FRE

39.62

+3.04%↑

PHIA

22.56

+4.2%↑

SAN

75.09

+2.65%↑

ARGX

667

-1.83%↓

SHL.DE

34.19

+3.48%↑

FRE

39.62

+3.04%↑

PHIA

22.56

+4.2%↑

SAN

75.09

+2.65%↑

ARGX

667

-1.83%↓

SHL.DE

34.19

+3.48%↑

FRE

39.62

+3.04%↑

PHIA

22.56

+4.2%↑

SAN

75.09

+2.65%↑

ARGX

667

-1.83%↓

SHL.DE

34.19

+3.48%↑

FRE

39.62

+3.04%↑

PHIA

22.56

+4.2%↑

Home・Aktien・Vetoquinol SA

Vetoquinol SA

Open

BrancheGesundheitswesen

71 0.71

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

70.2

Max

72.09

Schlüsselkennzahlen
By Trading Economics
Einkommen	7.2M 32M
Verkäufe	10M 268M
KGV Branchendurchschnitt	14.777 51.415
Dividendenrendite	1.25
Gewinnspanne	12.043
Angestellte	2,497
EBITDA	252M 301M

Empfehlungen
By TipRanks
Empfehlungen	Buy
12-Monats-Prognose	+54.93% upside

Dividenden
By Dow Jones
Dividendenrendite Branchendurchschnitt	1.25% 2.34%

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	-86M 849M
Vorheriger Eröffnungskurs	70.29
Vorheriger Schlusskurs	71

Nachrichtenstimmung

By Acuity

36%

64%

102 / 345 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Bearish Evidence

72.6 / 75.1 Unterstützung & Widerstand

Vetoquinol SA Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

18. Mai 2026, 23:10 UTC

Heiße Aktien

Stocks to Watch: Agilysys, XP

18. Mai 2026, 18:44 UTC

Wichtige Markttreiber

Claritev Shares Recover After Comments About DOJ

18. Mai 2026, 23:55 UTC

Ergebnisse

Review & Preview: Earnings' Last Gasp -- Barrons.com

18. Mai 2026, 23:47 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

18. Mai 2026, 23:47 UTC

Market Talk

Nikkei May Rise on Hopes for U.S.-Iran Deal -- Market Talk

18. Mai 2026, 23:37 UTC

Market Talk

Gold Rises Amid Hopes for U.S.-Iran Peace Deal -- Market Talk

18. Mai 2026, 22:31 UTC

Akquisitionen, Fusionen, Übernahmen

Lens Technology Ju Teng International Shares to Resume Trading on Hong Kong Exchange on May 19

18. Mai 2026, 22:30 UTC

Akquisitionen, Fusionen, Übernahmen

Lens Technology: Acquisition of Remaining Ju Teng International Shares to Cost HK$1.91B

18. Mai 2026, 22:30 UTC

Akquisitionen, Fusionen, Übernahmen

Lens Technology to Make Offer for Remainder Shares of Ju Teng International Only After Completion of Stake Purchase

18. Mai 2026, 22:25 UTC

Akquisitionen, Fusionen, Übernahmen

Lens Technology to Acquire 333.71M Ju Teng International Shares for HK$2.20 Each

18. Mai 2026, 22:24 UTC

Akquisitionen, Fusionen, Übernahmen

Lens Technology to Acquire 27.81% Stake in Ju Teng International for HK$734.17M

18. Mai 2026, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

18. Mai 2026, 20:50 UTC

Market Talk

Akquisitionen, Fusionen, Übernahmen

Financial Services Roundup: Market Talk

18. Mai 2026, 20:25 UTC

Ergebnisse

Correct: XP 1Q Total Client Assets BRL1.53T

18. Mai 2026, 20:23 UTC

Ergebnisse

XP 1Q Total Client Assets BRL1.53B

18. Mai 2026, 20:19 UTC

Ergebnisse

XP 1Q Adj EPS BRL2.49 >XP

18. Mai 2026, 20:19 UTC

Ergebnisse

XP 1Q Rev BRL4.73B >XP

18. Mai 2026, 19:10 UTC

Market Talk

Oil Presses Higher With No Hormuz Reopening in Sight -- Market Talk

18. Mai 2026, 19:00 UTC

Ergebnisse

5 Stocks with 5% Yields and Market-Beating Returns -- Barrons.com

18. Mai 2026, 18:52 UTC

Market Talk

U.S. Natural Gas Futures Gain As Weather Heats Up -- Market Talk

18. Mai 2026, 18:17 UTC

Market Talk

Akquisitionen, Fusionen, Übernahmen

NextEra's Dominion Acquisition Unlikely to Spur Wider Utility Consolidation -- Market Talk

18. Mai 2026, 17:22 UTC

Market Talk

Tokenized Assets Expected to be Over $1T By 2030 -- Market Talk

18. Mai 2026, 16:57 UTC

Akquisitionen, Fusionen, Übernahmen

The Long Regulatory Road Ahead for the NextEra-Dominion Deal -- Barrons.com

18. Mai 2026, 16:57 UTC

Market Talk

Global Energy Roundup: Market Talk

18. Mai 2026, 16:57 UTC

Market Talk

Commodities Higher as Traders Want Physical Assets -- Market Talk

18. Mai 2026, 16:54 UTC

Akquisitionen, Fusionen, Übernahmen

Vinci Doesn't Set Out Financial Details of Deal

18. Mai 2026, 16:50 UTC

Akquisitionen, Fusionen, Übernahmen

Vinci: Acquisition of New Brunswick-Based Group Stregthens Presence in Eastern Canada

18. Mai 2026, 16:49 UTC

Akquisitionen, Fusionen, Übernahmen

Vinci: Modern Group is Roadwork, Civil Engineering Specialist

18. Mai 2026, 16:49 UTC

Akquisitionen, Fusionen, Übernahmen

Vinci: Modern Group Made Revenue of Around 50 Mln Euros Last Year

18. Mai 2026, 16:48 UTC

Akquisitionen, Fusionen, Übernahmen

Vinci Buys Canada's Modern Group of Companies

Peer-Vergleich

Kursveränderung

Vetoquinol SA Prognose

Kursziel

By TipRanks

54.93% Vorteil

12-Monats-Prognose

Durchschnitt 110 EUR 54.93%

Hoch 110 EUR

Tief 110 EUR

Basierend auf 1 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Vetoquinol SA – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

1 ratings

Buy

Halten

Sell

Basierend auf 1 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Vetoquinol SA – Dist abgegeben haben.

Technischer Score

By Trading Central

72.6 / 75.1Unterstützung & Widerstand

Recent bearish events outweigh bullish events.

All events are bearish.

Stimmung

By Acuity

102 / 345 Ranking in Gesundheitswesen

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Vetoquinol SA

Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. It provides products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; infectious diseases; reproduction; behavior management; internal medicine; and cardiology-nephrology for cattle, sheep, pigs, poultry, dogs, cats, and horses. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol SA is a subsidiary of Soparfin SCA.